BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yung S, Yap DY, Chan TM. A review of advances in the understanding of lupus nephritis pathogenesis as a basis for emerging therapies. F1000Res 2020;9:F1000 Faculty Rev-905. [PMID: 32789005 DOI: 10.12688/f1000research.22438.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Manfredini M, Pedroni G, Bigi L, Apponi R, Murri Dello Diago A, Dattola A, Farnetani F, Pellacani G. Acquired White Oral Lesions with Specific Patterns: Oral Lichen Planus and Lupus Erythematosus. Dermatol Pract Concept 2021;11:e2021074. [PMID: 34123565 DOI: 10.5826/dpc.1103a74] [Reference Citation Analysis]
2 Su B, Chen B, Lu G. Relationship of complement activation pathway to clinical and pathological characteristics and renal outcome in patients with lupus nephritis. Z Rheumatol 2021. [PMID: 34152436 DOI: 10.1007/s00393-021-00999-0] [Reference Citation Analysis]
3 Dhillon S. Telitacicept: First Approval. Drugs 2021;81:1671-5. [PMID: 34463932 DOI: 10.1007/s40265-021-01591-1] [Reference Citation Analysis]